Like other -glutides, dulaglutide is proven to reduce risk of cardiovascular events
Similar content being viewed by others Introduction Tumor multidrug resistance (MDR) is the core clinical challenge responsible for the failure of antitumor therapy, disease recurrence, and even patient death
It is normally involved in the metabolism of every cell of the body, especially affecting DNA synthesis and regulation, but also fatty acids synthesis and energy production
See Supplementary table 3A for outcomes in human studies and Supplementary table 3B for outcomes in preclinical studies
Thus, a typical immune challenge increases TRP degradation and subsequently the generation of kynurenines
*Correspondence: Neda Roshanravan, [email protected] Dehghan, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers